4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000041
Director sold 1,666 shares at $18.42 ($30,688)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
SATO VICKI L · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-16 | Sale : show line 1 in the form 10b5-1 | −1,666 | $18.42 | $30,688 | 123,041 | D |
| Open-market sales · 1,666 sh · avg $18.42 · $30,688 | ||||||
Loading xslF345X05/wk-form4_1705620357.xml…